CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Clinical trial NCT04526288 · TERMINATED

Trial details

NCT number: NCT04526288
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm

Start date: 2021-08-09
Primary completion: 2023-08-27
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.